175 related articles for article (PubMed ID: 38278630)
1. Systematic review of cost projections of new vaccine introduction.
Levin A; Yeung KHT; Hutubessy R
Vaccine; 2024 Feb; 42(5):1042-1050. PubMed ID: 38278630
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Oral Cholera Vaccination Delivery Cost in Low- and Middle-Income Countries: An Analysis Based on Systematic Review.
Mogasale V; Ramani E; Wee H; Kim JH
PLoS Negl Trop Dis; 2016 Dec; 10(12):e0005124. PubMed ID: 27930668
[TBL] [Abstract][Full Text] [Related]
4. Costs of introducing and delivering HPV vaccines in low and lower middle income countries: inputs for GAVI policy on introduction grant support to countries.
Levin A; Wang SA; Levin C; Tsu V; Hutubessy R
PLoS One; 2014; 9(6):e101114. PubMed ID: 24968002
[TBL] [Abstract][Full Text] [Related]
5. Costs of human papillomavirus vaccine delivery in low- and middle-income countries: A systematic review.
Slavkovsky R; Callen E; Pecenka C; Mvundura M
Vaccine; 2024 Feb; 42(6):1200-1210. PubMed ID: 38302338
[TBL] [Abstract][Full Text] [Related]
6. Systematic review of incremental non-vaccine cost estimates used in cost-effectiveness analysis on the introduction of rotavirus and pneumococcal vaccines.
De la Hoz-Restrepo F; Castañeda-Orjuela C; Paternina A; Alvis-Guzman N
Vaccine; 2013 Jul; 31 Suppl 3():C80-7. PubMed ID: 23777697
[TBL] [Abstract][Full Text] [Related]
7. National decision-making for the introduction of new vaccines: A systematic review, 2010-2020.
Donadel M; Panero MS; Ametewee L; Shefer AM
Vaccine; 2021 Apr; 39(14):1897-1909. PubMed ID: 33750592
[TBL] [Abstract][Full Text] [Related]
8. Strengthening national decision-making on immunization by building capacity for economic evaluation: Implementing ProVac in Europe.
Blau J; Hoestlandt C; D Clark A; Baxter L; Felix Garcia AG; Mounaud B; Mosina L
Vaccine; 2015 May; 33 Suppl 1():A34-9. PubMed ID: 25919171
[TBL] [Abstract][Full Text] [Related]
9. Systematic review of the costs and effectiveness of interventions to increase infant vaccination coverage in low- and middle-income countries.
Munk C; Portnoy A; Suharlim C; Clarke-Deelder E; Brenzel L; Resch SC; Menzies NA
BMC Health Serv Res; 2019 Oct; 19(1):741. PubMed ID: 31640687
[TBL] [Abstract][Full Text] [Related]
10. How much does it cost to get a dose of vaccine to the service delivery location? Empirical evidence from Vietnam's Expanded Program on Immunization.
Mvundura M; Kien VD; Nga NT; Robertson J; Cuong NV; Tung HT; Hong DT; Levin C
Vaccine; 2014 Feb; 32(7):834-8. PubMed ID: 24370713
[TBL] [Abstract][Full Text] [Related]
11. Cost of introducing and delivering RTS,S/AS01 malaria vaccine within the malaria vaccine implementation program.
Baral R; Levin A; Odero C; Pecenka C; Tanko Bawa J; Antwi-Agyei KO; Amponsa-Achaino K; Chisema MN; Eddah Jalango R; Mkisi R; Gordon S; Morgan W; Muhib F
Vaccine; 2023 Feb; 41(8):1496-1502. PubMed ID: 36710234
[TBL] [Abstract][Full Text] [Related]
12. Impact and cost-effectiveness of measles vaccination through microarray patches in 70 low-income and middle-income countries: mathematical modelling and early-stage economic evaluation.
Fu H; Abbas K; Malvolti S; Gregory C; Ko M; Amorij JP; Jit M
BMJ Glob Health; 2023 Nov; 8(11):. PubMed ID: 37949503
[TBL] [Abstract][Full Text] [Related]
13. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
[TBL] [Abstract][Full Text] [Related]
14. Cost of human papillomavirus vaccine delivery in a single-age cohort, routine-based vaccination program in Senegal.
Brennan T; Hidle A; Doshi RH; An Q; Loharikar A; Casey R; Badiane O; Ndiaye A; Diallo A; Loko Roka J; Mejia N; Abimbola T
Vaccine; 2022 Mar; 40 Suppl 1(Suppl 1):A77-A84. PubMed ID: 34955325
[TBL] [Abstract][Full Text] [Related]
15. Costs and cost-effectiveness of influenza illness and vaccination in low- and middle-income countries: A systematic review from 2012 to 2022.
Gharpure R; Chard AN; Cabrera Escobar M; Zhou W; Valleau MM; Yau TS; Bresee JS; Azziz-Baumgartner E; Pallas SW; Lafond KE
PLoS Med; 2024 Jan; 21(1):e1004333. PubMed ID: 38181066
[TBL] [Abstract][Full Text] [Related]
16. A systematic review of vaccine preventable disease surveillance cost studies.
Erondu NA; Ferland L; Haile BH; Abimbola T
Vaccine; 2019 Apr; 37(17):2311-2321. PubMed ID: 30902482
[TBL] [Abstract][Full Text] [Related]
17. Systematic review of economic evaluations of vaccination programs in mainland China: Are they sufficient to inform decision making?
Pan XF; Griffiths UK; Pennington M; Yu H; Jit M
Vaccine; 2015 Nov; 33(46):6164-72. PubMed ID: 26435189
[TBL] [Abstract][Full Text] [Related]
18. Cost and operational context for national human papillomavirus (HPV) vaccine delivery in six low- and middle-income countries.
Mvundura M; Slavkovsky R; Debellut F; Naddumba T; Bayeh A; Ndiaye C; Anena J; Vodicka E; Diop A; Gamage D; Musanabaganwa C; Tatkan G; Driwale A; Zelalem M; Badiane O; Ginige S; Hamilton E; Sibomana H; Lakew Y; Uwinkindi F; Dhufera A; Ampeire I; Kumar S; Lamontagne DS
Vaccine; 2023 Nov; 41(49):7435-7443. PubMed ID: 37949752
[TBL] [Abstract][Full Text] [Related]
19. A cost comparison of introducing and delivering pneumococcal, rotavirus and human papillomavirus vaccines in Rwanda.
Ngabo F; Levin A; Wang SA; Gatera M; Rugambwa C; Kayonga C; Donnen P; Lepage P; Hutubessy R
Vaccine; 2015 Dec; 33(51):7357-7363. PubMed ID: 26519548
[TBL] [Abstract][Full Text] [Related]
20. Projecting the cost of introducing typhoid conjugate vaccine (TCV) in the national immunization program in Malawi using a standardized costing framework.
Debellut F; Mkisi R; Masoo V; Chisema M; Mwagomba D; Mtenje M; Limani F; Mategula D; Zimba B; Pecenka C
Vaccine; 2022 Mar; 40(12):1741-1746. PubMed ID: 35153097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
